Allergic disorders are probably the most common chronic diseases worldwide. While variations in reported prevalence across different countries exist, depending on geographical particularities and methodological heterogeneity between studies, it is universally demonstrated that the number of allergic patients has risen profoundly over the second half of the last century, posing significant morbidity, impaired quality of life and financial burden on healthcare systems in westernised countries. In the UK, which is among the countries with the highest incidence worldwide, 1 it has recently been estimated that about one-third of the entire population is affected by some type of allergic disease at some point in their lives.
Editorials
Allergic disorders are probably the most common chronic diseases worldwide. While variations in reported prevalence across different countries exist, depending on geographical particularities and methodological heterogeneity between studies, it is universally demonstrated that the number of allergic patients has risen profoundly over the second half of the last century, posing significant morbidity, impaired quality of life and financial burden on healthcare systems in westernised countries. In the UK, which is among the countries with the highest incidence worldwide, 1 it has recently been estimated that about one-third of the entire population is affected by some type of allergic disease at some point in their lives. 2 Although the demands for allergy services are burgeoning, only a small number of allergy specialists and dedicated allergy clinics are generally available. 3 Within the UK National Health Service (NHS), the responsibility for diagnosis and management of the vast majority of these allergic patients largely falls to primary care services. The quality of allergy training and adequacy of general practitioners (GPs) in meeting this role is therefore critical.
In two consecutive nationwide surveys of UK GPs in 2002 and 2009, less than half of the responders reported having had any type of allergy training, most of which was as undergraduate medical students. 4, 5 Quality of training was rated low, and only a minority of GPs reported being confident in their allergy knowledge. This was also the case in their ability to perform essential diagnostic procedures (such as skin prick testing), or competence in dealing with systemic manifestations of allergy. Overall, these national surveys of primary care providers reinforced the prevailing view that allergy care provision is not yet optimal in the UK, due to both limited access to specialised care as well as significant lack of specific training of the actual allergy service providers. 3, 6 In this issue of the PCRJ, Ellis and colleagues attempt to take the analysis a step further by assessing, for the first time, the view of head officers directly in charge of GP training. 7 The authors conducted an internet-based, cross-sectional nationwide survey of General Practice Specialty Training (GPST) programme directors, enquiring about the quality of allergy training as part of GPST programmes, as well as the perceived needs for improvement of GP education in allergy. The findings are of particular interest, as they essentially confirm the educational gaps highlighted by the two previous GP surveys. 4, 5 According to the directors' feedback, no specific training is being offered to GP trainees in as much as one-third of GPST programmes. The percentage is likely to be even higher: considering that directors representing 40% of programmes did not respond to the survey, it is reasonable to expect that the rate of unfavourable answers among these non-responders would be higher.
Moreover, even when allergy training is reported to be delivered, the perceived quality of educational schemes appears to vary with respect to different types of allergy. Specifically, diagnosis and management of organ-based allergic disorders -such as allergic rhinitis and asthma -were considered adequately covered by most respondents; in contrast, GPST directors did not feel as confident about guidance on diseases with systemic manifestations, especially food allergy. In essence, similar findings of the earlier GP studies 4 are now corroborated, suggesting validity of these results. 7 The lack of confidence of both GP trainers and trainees with regard to the provision of food allergy training is of particular concern. Food allergy is on the rise in most westernised countries, emerging as a second wave of the allergy epidemic. 8 While the prevalence of respiratory allergy appears to have probably reached a plateau, and experience in managing it has developed over the years, the frequency and severity of food allergy is apparently increasing, primarily affecting children.
9,10 A similar trend is evident in the UK, with the frequency of hospital admissions for food allergy having increased 5-fold in 15 years. 10 With a shortage of allergy specialists and inadequately trained GPs, the NHS may face substantial problems dealing with this food allergy epidemic. The implications are obvious, both in terms of morbidity and healthcare cost increases.
11
Having highlighted the educational needs of UK GPs, it should be noted that, with few exceptions, similar unmet needs are recognised all over Europe, as well as in the USA. 12 One exception is Finland, with its National Allergy Program which includes standardised approaches and systematic educational efforts. 13 Consequently, several European bodies are currently focusing their efforts in either standardising, or lobbying for, improved allergy education in both specialist and primary care. The Allergy Section of the European Union of Medical Specialists (UEMS), in collaboration with the European Academy of Allergy and Clinical Immunology (EAACI), has prepared an 'Allergy Blueprint', in which the minimum training requirements for allergy care are described; the respective roles of specialist and GP are also touched upon. 14 between specialists and primary care physicians, to assist harmonisation, and to design and deploy relevant educational tools (see www.eaaci.net).
However, the impact of allergies has only recently been recognised at the political level in Europe, mostly in relation to respiratory allergies. 15 This is an important step, but it lags behind the observed epidemiological trends with increases in systemic disease entities such as food allergy. In all, there is little doubt that recognition and prioritisation of allergy education in primary care is probably the only way to improve patient outcomes and to prevent devastating consequences in public health.
